Title of article :
Human embryonic stem cells and good manufacturing practice: Report of a 1- day workshop held at Stem Cell Biology Research Center, Yazd, 27th April 2017
Author/Authors :
Akyash, Fatemeh Stem Cell Biology Research Center - Yazd Reproductive Sciences Institute - Shahid Sadoughi University of Medical Sciences, Yazd , Sadeghian-Nodoushan, Fatemeh Stem Cell Biology Research Center - Yazd Reproductive Sciences Institute - Shahid Sadoughi University of Medical Sciences, Yazd , Sadat Tahajjodi, Somayyeh Stem Cell Biology Research Center - Yazd Reproductive Sciences Institute - Shahid Sadoughi University of Medical Sciences, Yazd , Nikukar, Habib Stem Cell Biology Research Center - Yazd Reproductive Sciences Institute - Shahid Sadoughi University of Medical Sciences, Yazd , Farashahi Yazd, Ehsan Stem Cell Biology Research Center - Yazd Reproductive Sciences Institute - Shahid Sadoughi University of Medical Sciences, Yazd , Azimzadeh, Mostafa Stem Cell Biology Research Center - Yazd Reproductive Sciences Institute - Shahid Sadoughi University of Medical Sciences, Yazd , Aflatoonian, Behrouz Stem Cell Biology Research Center - Yazd Reproductive Sciences Institute - Shahid Sadoughi University of Medical Sciences, Yazd , Moore, Harry D. Centre for Stem Cell Biology (CSCB) - Department of Biomedical Sciences - The University of Sheffield - Western Bank - Alfred Denny Building - Sheffield S10 2TN - UK
Abstract :
This report explains briefly the minutes of a 1-day workshop entitled; “human
embryonic stem cells (hESCs) and good manufacturing practice (GMP)” held by
Stem Cell Biology Research Center based in Yazd Reproductive Sciences Institute
at Shahid Sadoughi University of Medical Sciences, Yazd, Iran on 27th April 2017.
In this workshop, in addition to the practical sessions, Prof. Harry D. Moore from
Centre for Stem Cell Biology, University of Sheffield, UK presented the challenges
and the importance of the biotechnology of clinical-grade human embryonic stem
cells from first derivation to robust defined culture for therapeutic applications.
Keywords :
Stem Cells , Human Embryonic Stem Cell , Good Manufacturing Practice , Cell Therapy